Literature DB >> 16682788

Brain cytokines and chemokines: roles in ischemic injury and pain.

Masabumi Minami1, Takahiro Katayama, Masamichi Satoh.   

Abstract

Cytokines and chemokines were originally identified as essential mediators for inflammatory and immune responses. Enhanced production and release of cytokines/chemokines are observed also in the central nervous system (CNS) under diverse pathological conditions. There is growing evidence showing that brain cytokines/chemokines play crucial roles in the neuro-glio-vascular interaction underlying the pathology of various brain disorders and therefore are potential targets for development of novel and effective therapeutics for CNS diseases. Here the evidence of the involvement of cytokines/chemokines in ischemic brain injury and pain is reviewed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16682788     DOI: 10.1254/jphs.crj06005x

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  36 in total

1.  Hyperbaric Oxygen Preconditioning Protects Against Cerebral Ischemia/Reperfusion Injury by Inhibiting Mitochondrial Apoptosis and Energy Metabolism Disturbance.

Authors:  Shun-Da Wang; Ying-Ying Fu; Xin-Yuan Han; Zhi-Jun Yong; Qing Li; Zhen Hu; Zhen-Guo Liu
Journal:  Neurochem Res       Date:  2021-01-16       Impact factor: 3.996

2.  Temporal mRNA profiles of inflammatory mediators in the murine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine model of Parkinson's disease.

Authors:  R Pattarini; R J Smeyne; J I Morgan
Journal:  Neuroscience       Date:  2007-01-29       Impact factor: 3.590

3.  The chemokine CCL2 activates p38 mitogen-activated protein kinase pathway in cultured rat hippocampal cells.

Authors:  Jungsook Cho; Donna L Gruol
Journal:  J Neuroimmunol       Date:  2008-06-27       Impact factor: 3.478

4.  Neuroprotective Effects of Lycium barbarum Polysaccharide on Focal Cerebral Ischemic Injury in Mice.

Authors:  Peng Zhao; Ru Zhou; Xiao-Yun Zhu; Gang Liu; Yu-Ping Zhao; Peng-Sheng Ma; Wei Wu; Yang Niu; Tao Sun; Yu-Xiang Li; Jian-Qiang Yu; Zhong-Ming Qian
Journal:  Neurochem Res       Date:  2017-05-15       Impact factor: 3.996

5.  Gastrodin alleviates cerebral ischemic damage in mice by improving anti-oxidant and anti-inflammation activities and inhibiting apoptosis pathway.

Authors:  Zhengwu Peng; Shiquan Wang; Guanjie Chen; Min Cai; Rui Liu; Jiao Deng; Jiangzheng Liu; Tao Zhang; Qingrong Tan; Chunxu Hai
Journal:  Neurochem Res       Date:  2015-01-13       Impact factor: 3.996

6.  Astrocytic P2Y(1) receptor is involved in the regulation of cytokine/chemokine transcription and cerebral damage in a rat model of cerebral ischemia.

Authors:  Kazuya Kuboyama; Hideki Harada; Hidetoshi Tozaki-Saitoh; Makoto Tsuda; Kazuo Ushijima; Kazuhide Inoue
Journal:  J Cereb Blood Flow Metab       Date:  2011-04-13       Impact factor: 6.200

Review 7.  To Treat or Not to Treat: The Effects of Pain on Experimental Parameters.

Authors:  Norman C Peterson; Elizabeth A Nunamaker; Patricia V Turner
Journal:  Comp Med       Date:  2017-12-01       Impact factor: 0.982

Review 8.  Hypertensive encephalopathy in patients with chronic renal failure caused by stopping antihypertensive agents: a report of two cases.

Authors:  Mari Nakabou; Tatsuya Kai; Tetsuya Maeshima; Ken Kanamasa
Journal:  Clin Exp Nephrol       Date:  2009-12-15       Impact factor: 2.801

9.  Analgesic effect of a broad-spectrum dihydropyridine inhibitor of voltage-gated calcium channels.

Authors:  Vinicius M Gadotti; Chris Bladen; Fang Xiong Zhang; Lina Chen; Miyase Gözde Gündüz; Rahime Şimşek; Cihat Şafak; Gerald W Zamponi
Journal:  Pflugers Arch       Date:  2015-08-19       Impact factor: 3.657

10.  Anti-hyperalgesic activity of the aqueous and methanol extracts of the leaves of Pittosporum mannii Hook on CFA-induced persistent inflammatory pain.

Authors:  Bibiane Aimée Wandji; Francis Desire Tatsinkou Bomba; Pepin Alango Nkeng-Efouet; Basile Nganmegne Piegang; Albert Kamanyi; Télesphore Benoît Nguelefack
Journal:  Inflammopharmacology       Date:  2017-08-29       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.